drugset
drugset / Trial / NCT04162314

Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Non-infectious and Idiopathic Uveitis

NCT04162314 ↗

Phase 2/3 Unknown 20 enrolled Faculty of Medicine, University of Indonesia
RandomizedParallel-groupTriple-blindTreatment

Summary

To investigate the effect of Beta-1,3/1,6-D-Glucan from mycelium extract of Indonesian Ganoderma lucidum as an adjuvant to methylprednisolone for non-infectious and idiopathic uveitis

Timeline

Start
2020-01-21
Primary completion
2021-09
Completion
2021-12

Drugs

EvaluationDrugModalityDoseRoute
Subject beta-glucan Other / unclassified 180 mg —

Indications

uveitis